Ewing sarcoma/PNET: 27 years of experience in Slovenia

Pediatric Hematology and Oncology
Ziva Pohar MarinsekBerta Jereb

Abstract

The study includes 91 patients treated for Ewing sarcoma between 1972 and 2002. Forty were younger and 51 were older than 16. The overall 5-year survival was 36%: 53.5% in the younger and 22.5% in the older age group. Among patients with localized disease, 5-year survival was 58% in younger and 25.5% in the older. Survival was similar whether patients received three treatment modalities or chemotherapy combined with either surgery or radiotherapy. Recurrence was noted in 47 out of 75 patients with localized disease, most commonly as local recurrence or lung metastases. Among 18 evaluated patients, 14 had minor physical defects and 4 had severe late treatment effects (sterility in 3 and secondary osteogenic sarcoma in 1).

References

Mar 1, 1991·International Journal of Radiation Oncology, Biology, Physics·T J KinsellaM E Horowitz
Oct 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M E NesbitJ M Kissane
Jan 1, 1986·Pediatric Hematology and Oncology·B JerebP Exelby
Dec 1, 1984·International Journal of Radiation Oncology, Biology, Physics·R G EvansJ E Bruckman
Jul 15, 1995·International Journal of Radiation Oncology, Biology, Physics·J DunstC Rübe
Sep 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S P ScullyM C Gebhardt
Oct 15, 1995·Cancer·R S YangR al-Shaikh
Apr 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A ZoubekH Kovar
Jun 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A W CraftD Pearson
Nov 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A CraftI Lewis
Jan 7, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G BacciP Picci
Feb 16, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A G ShankarA W Craft
Aug 30, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S J CotterillA W Craft
Mar 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M PaulussenH Jürgens
Feb 2, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M PaulussenH Jürgens
Feb 22, 2002·Critical Reviews in Oncology/hematology·S Burdach, H Jürgens
Dec 31, 2002·International Journal of Radiation Oncology, Biology, Physics·Andreas SchuckHeribert Jürgens
Mar 4, 2003·Archives of Surgery·Robert C G Martin, Murray F Brennan
Mar 26, 2003·Medical and Pediatric Oncology·Carlos Rodriguez-GalindoAlberto S Pappo
Jul 30, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S J StraussJ S Whelan
Dec 12, 2003·Cancer·Bruno FuchsMichael G Rock
Mar 30, 2004·Pediatric Blood & Cancer·Perrine Marec-Bérard, Thierry Philip
Jan 1, 2005·Pediatric Hematology and Oncology·M Tezer KutlukMünevver Büyükpamukçu

❮ Previous
Next ❯

Citations

Jul 27, 2010·Journal of the National Cancer Institute·Jill P GinsbergKevin C Oeffinger
Mar 20, 2015·Oncology Letters·Xiao-Tong Meng, Shi-Sheng He
Sep 18, 2009·Pediatric Blood & Cancer·Neriman SariInci Ergürhan Ilhan
Oct 1, 2007·The Canadian Journal of Plastic Surgery = Journal Canadien De Chirurgie Plastique·Tatiana Karine Simon CypelRonald Melvin Zuker

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.